Cargando…
Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa
BACKGROUND: Current available treatments for Helicobacter pylori eradication are chosen according to local clarithromycin and metronidazole resistance prevalence. The aim of this study was to estimate, by means of molecular methods, both clarithromycin and metronidazole resistance in gastric mucosa...
Autores principales: | Gonzalez-Hormazabal, Patricio, Musleh, Maher, Escandar, Susana, Valladares, Hector, Lanzarini, Enrique, Castro, V. Gonzalo, Jara, Lilian, Berger, Zoltan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011593/ https://www.ncbi.nlm.nih.gov/pubmed/29925321 http://dx.doi.org/10.1186/s12876-018-0820-0 |
Ejemplares similares
-
NOD1 rs2075820 (p.E266K) polymorphism is associated with gastric cancer among individuals infected with cagPAI-positive H. pylori
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2021) -
Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
por: Gonzalez-Hormazabal, Patricio, et al.
Publicado: (2018) -
High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis
por: Arenas, A., et al.
Publicado: (2019) -
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients
por: Bilgilier, Ceren, et al.
Publicado: (2016) -
Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains
por: Gong, Eun Jeong, et al.
Publicado: (2020)